A panel discussion from a recent Microsoft summit offered insights on how tech companies are closely collaborating with the pharma industry as they seek to repair and improve manufacturing supply chain issues exposed by the Covid-19 pandemic.
A panel discussion from a recent Microsoft summit offered insights on how tech companies are closely collaborating with the pharma industry as they seek to repair and improve manufacturing supply chain issues exposed by the Covid-19 pandemic. They touch on how increasing collaboration between software and pharma companies creates greater transparency across the supply chain which is essential to the complex processes of drug development. Greater transparency improves the ability by pharma companies to not only identify fraudulent behavior and stop counterfeit drugs, but also to aggregate and analyze data in new and unique ways to unify partners. |
|
No comments